Silo Pharma (SILO)

• Market cap: $4.66M
• 1 day: -2.75%
• 5 days: -6.72%
• 1 month: 21.95%
• 3 months: -20.24%
• 6 months: -42.67%
• Year to date: 4.29%
• 1 year: -72.44%
• 5 years: -93.14%
• 10 years: -93.14%
• Sector: Healthcare
• Industry: Biotechnology

About: SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Employees: 3